Publications
261 results found
Fox KF, Nuttall M, Wood DA, et al., 2001, A cardiac prevention and rehabilitation programme for all patients at first presentation with coronary artery disease, HEART, Vol: 85, Pages: 533-538, ISSN: 1355-6037
- Author Web Link
- Cite
- Citations: 11
Wood DA, Fox KF, Gibbs SR, 2001, Rapid cardiology - for chest pain, breathlessness and palpitations, QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, Vol: 94, Pages: 177-178, ISSN: 1460-2725
- Author Web Link
- Cite
- Citations: 5
Kotseva K, Wood D, De Backer G, et al., 2001, Clinical reality of coronary prevention guidelines:: a comparison of EUROASPIRE I and II in nine countries, LANCET, Vol: 357, Pages: 995-1001, ISSN: 0140-6736
- Author Web Link
- Cite
- Citations: 618
Braunwald E, Wood D, 2001, Clinical utility of statins in acute coronary treatment: Modifying disease or modifying numbers - Introduction, ATHEROSCLEROSIS, Pages: 1-2, ISSN: 0021-9150
Braunwald E, Wood D, 2001, Clinical utility of statins in acute coronary treatment: Modifying disease or modifying numbers - Introduction, ATHEROSCLEROSIS SUPP, Vol: 2, Pages: 1-2, ISSN: 1567-5688
Behr ER, Casey A, O'Donoghue A, et al., 2001, A national survey of Sudden Death Syndrome (SDS): Results from cardiological evaluation of first degree relatives, JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, Vol: 37, Pages: 87A-87A, ISSN: 0735-1097
Wood D, 2001, The treatment potential in preventive cardiology, Pages: 3-8, ISSN: 0021-9150
Fox KF, Cowie MR, Wood DA, et al., 2001, Coronary artery disease as the cause of incident heart failure in the population, EUROPEAN HEART JOURNAL, Vol: 22, Pages: 228-236, ISSN: 0195-668X
- Author Web Link
- Cite
- Citations: 254
Wood D, 2001, Established and emerging cardiovascular risk factors, AMERICAN HEART JOURNAL, Vol: 141, Pages: S49-S57, ISSN: 0002-8703
- Author Web Link
- Cite
- Citations: 123
Wood D, 2001, The treatment potential in preventive cardiology, XXIInd Congress of the European-Society-of-Cardiology, Publisher: ELSEVIER IRELAND LTD, Pages: 3-8, ISSN: 1567-5688
- Author Web Link
- Cite
- Citations: 5
Braunwald E, Wood D, 2001, Clinical utility of statins in acute coronary treatment: Modifying disease or modifying numbers - Introduction, ATHEROSCLEROSIS SUPPLEMENTS, Vol: 2, Pages: 1-2, ISSN: 1567-5688
- Author Web Link
- Cite
- Citations: 2
Wood D, 2001, The treatment potential in preventive cardiology, ATHEROSCLEROSIS SUPP, Vol: 2, Pages: 3-8, ISSN: 1567-5688
<p>The Joint European Societies - European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension - 1998 recommendations on prevention of coronary heart disease (CHD) in clinical practice set priorities and goals. The top priority is patients with established CHD, or other atherosclerotic disease, because they are already under the care of cardiologists and are at high risk of further morbidity and mortality. The lifestyle goals are to stop smoking, make healthy food choices and be active physically. The risk factor goals are a BP < 140/90 mmHg, total cholesterol < 5.0 mmol/l (190 mg/dl) and LDL-cholesterol < 3.0 mmol/l (115 mg/dl). The appropriate use of prophylactic drug therapies - aspirin, beta-blockers, ACE inhibitors, lipid modification therapies and anticoagulants - is also a recommended goal. The final goal is to screen relatives of patients with premature CHID (men < 55 years and women < 65 years). Surveys of clinical practice such as EUROASPIRE (European Action on Secondary Prevention) have shown risk can be further reduced in patients with established CHD because many are not achieving these lifestyle and risk factor goals. So there is considerable potential to raise the standard of preventive care for coronary patients through more effective lifestyle intervention and the use of drug therapies with proven efficacy. For the patient, this will mean a longer life with better quality. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.</p>
Ashton WD, Nanchahal K, Wood DA, 2001, Body mass index and metabolic risk factors for coronary heart disease in women, EUROPEAN HEART JOURNAL, Vol: 22, Pages: 46-55, ISSN: 0195-668X
- Author Web Link
- Cite
- Citations: 58
EUROASPIRE Study Group, 2001, Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme, Eur Heart J, Vol: 22, Pages: 554-572, ISSN: 0195-668X
Wood D, 2001, Asymptomatic individuals - risk stratification in the prevention of coronary heart disease, BRITISH MEDICAL BULLETIN, Vol: 59, Pages: 3-16, ISSN: 0007-1420
- Author Web Link
- Cite
- Citations: 13
Wood D, 2000, Practical management of the patient at risk, Pfizer/Parke-Davis Satellite Symposium held during the XXIst Congress of the European-Society-of-Cardiology, Publisher: OXFORD UNIV PRESS, Pages: L7-L11, ISSN: 1520-765X
- Author Web Link
- Cite
- Citations: 1
Vanuzzo D, Pilotto L, Ambrosio GB, et al., 2000, Potential for cholesterol lowering in secondary prevention of coronary heart disease in Europe:: findings from EUROASPIRE study, ATHEROSCLEROSIS, Vol: 153, Pages: 505-517, ISSN: 0021-9150
- Author Web Link
- Cite
- Citations: 23
Fox KF, Cowie MR, Wood DA, et al., 2000, A Rapid Access Heart Failure Clinic provides a prompt diagnosis and appropriate management of new heart failure presenting in the community, EUROPEAN JOURNAL OF HEART FAILURE, Vol: 2, Pages: 423-429, ISSN: 1388-9842
- Author Web Link
- Cite
- Citations: 39
Cowie MR, Fox KF, Wood DA, et al., 2000, N-terminal pro-BNP predicts prognosis in patients presenting with heart failure for the first time better than does N-terminal pro-ANP or BNP, CIRCULATION, Vol: 102, Pages: 781-781, ISSN: 0009-7322
- Author Web Link
- Cite
- Citations: 2
Bowker TJ, Turner RM, Wood DA, et al., 2000, A national Survey of Acute Myocardial Infarction and Ischaemia (SAMII) in the UK: characteristics, management and in-hospital outcome in women compared to men in patients under 70 years, EUROPEAN HEART JOURNAL, Vol: 21, Pages: 1458-1463, ISSN: 0195-668X
- Author Web Link
- Cite
- Citations: 34
Ashton WD, Nanchahal K, Wood DA, 2000, Leisure-time physical activity and coronary risk factors in women, JOURNAL OF CARDIOVASCULAR RISK, Vol: 7, Pages: 259-266, ISSN: 1350-6277
- Author Web Link
- Cite
- Citations: 16
Nanchahal K, Ashton WD, Wood DA, 2000, Association between blood pressure, the treatment of hypertension, and cardiovascular risk factors in women, JOURNAL OF HYPERTENSION, Vol: 18, Pages: 833-841, ISSN: 0263-6352
- Author Web Link
- Cite
- Citations: 19
Fox KF, Cowie MR, Wood DA, et al., 2000, Heart failure with normal systolic function: A population based study, Heart, Vol: 83, ISSN: 1355-6037
Most cases of heart failure (HF) are due to abnormal left ventricular (LV) systolic function. If systolic function is normal (NSF), the cause of HF may be due to diastolic dysfunction. We reviewed cases in a population based study of HF to identify those with NSF. All incident cases of HF in a large district of SE London (population 292,000) were identified by surveillance of hospital admissions and through a Rapid Access Heart Failure Clinic to which GPs referred all suspected new cases of HF. The definition of HF, based on the European Society of Cardiology guidelines, was that a case should have symptoms consistent with HF, signs of fluid retention (pulmonary or peripheral oedema), a cardiac abnormality, and wherever possible or in cases of doubt, a response to therapy for HF. Cases were assessed with history, examination, ECG, CXR and echocardiogram (TTE) before presentation to a panel of 3 cardiologists (DAW, AJC, GCS) to determine if a case fulfilled the definition of HF. Over 15 months 332 incident cases of HF were identified with 196 cases (59%) 75 years (population incidence 0.9 cases/1000 population/year). We used the criteria of a non-dilated LV (LVEDD < 5.6cm), a fractional shortening (FS) ≥ 25% or normal LV systolic function on visual assessment, and no valve abnormality to identify cases of HF with NSF. TTE data was missing on 21 non-valvular cases. Of the 311 remaining cases 53 / 311 (17%) were HF with NSF. 18 /131 (14%) were aged < 75 years and 35 /180 (19%) aged ≥ 75 years. 20 / 53 (38%) of these cases were in AF (compared with 34% of all HF cases) where interpretation of diastolic function is more difficult. 22 / 53 (42%) had a septal thickness >1.1cm (found in 34% of all cases). 26 / 53 (49%) were NYHA 4 (75% of all HF cases were in NYHA 4). These proportions are dependent on the definition of NSF. Using a cut off of a LVEDD < 6.0 and a FS ≥ 20% would increase the number of cases of HF with NSF to 84 / 311 (27%). The proportio
Cowie MR, Wood DA, Coats AJS, et al., 2000, Survival of patients with a new diagnosis of heart failure: a population based study, HEART, Vol: 83, Pages: 505-510, ISSN: 1355-6037
- Author Web Link
- Cite
- Citations: 392
Wood D, De Backer G, Faergeman O, et al., 2000, [The prevention of coronary disease in clinical practice. The recommendations of the Second Joint Task Force of European Societies on the Prevention of Coronary Pathology. Società Europea di Cardiologia, Società Europea dell'Aterosclerosi, Società Europea dell'Ipertensione]., Ital Heart J Suppl, Vol: 1, Pages: 692-698, ISSN: 1129-4728
British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, 2000, Joint British recommendations on prevention of coronary heart disease in clinical practice: summary, Br Med J, Vol: 320, Pages: 705-708
Alpert JS, Antman E, Apple F, et al., 2000, Myocardial infarction redefined - A consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction, Eur Heart J, Vol: 21, Pages: 1502-1513
Nanchahal K, Ashton D, 2000, Alcohol consumption, metabolic cardiovascular risk factors and hypertension in women, Int J Epid, Vol: 29, Pages: 57-64
Wood David A, Flint J, 2000, Strategies for reducing cardiovascular risk in the NHS, Royal College of Physicians: Horizons in Medicine, Vol: No 12
This data is extracted from the Web of Science and reproduced under a licence from Thomson Reuters. You may not copy or re-distribute this data in whole or in part without the written consent of the Science business of Thomson Reuters.